Molecular prognostic markers in pancreatic cancer: A systematic review

Angiogenesis in cancer, vascular, rheumatoid and other disease

Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627

What Is the Evidence That Tumors Are Angiogenesis Dependent?

Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650

BCL-2 family members and the mitochondria in apoptosis

Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641

β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601

p21 is a universal inhibitor of cyclin kinases

Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368

The Transforming Growth Factor-beta Family

Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114

The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing

Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476

Apoptosis induced by anticancer drugs

Hickman, J. A. (1992) · Cancer and Metastasis Review · doi:10.1007/bf00048059 · Cited by 863

Basic fibroblast growth factor induces angiogenesis in vitro.

Montesano, R., Vassalli, J. D., Baird, A., Guillemin, R., & Orci, L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7297 · Cited by 844

How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture.

Folkman, J. (1986) · PubMed · Cited by 732

Tumor-suppressive pathways in pancreatic carcinoma.

Rozenblum, E., Schutte, M. E. M., Goggins, M., Hahn, S. A., Panzer, S., ZAHURAK, M. L., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., et al. (1997) · PubMed · Cited by 693

K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.

Hruban, R. H., van Mansfeld, A. D. M., Offerhaus, G. J. A., van Weering, D. H. J., Allison, D. C., Goodman, S. N., Kensler, T. W., Bose, K., Cameron, J. L., & Bos, J. L. (1993) · PubMed Central · Cited by 650

Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis

Joyce, J. A., Baruch, A., Chehade, K., Meyer-Morse, N., Giraudo, E., Tsai, F.-Y., Greenbaum, D. C., Hager, J. H., Bogyo, M., & Hanahan, D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00111-4 · Cited by 645

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

Smit, V. T. H. B. M., Boot, A. J. M., Smits, A. M. M., Fleuren, G. J., Cornelisse, C. J., & Bos, J. L. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.16.7773 · Cited by 626

Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival

Friess, H., Yamanaka, Y., Büchler, M., Ebert, M., Beger, H. G., Gold, L. I., & Korc, M. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91084-u · Cited by 522

Racial/ethnic patterns of cancer in the United States, 1988-1992.

Miller, B.-A., Kolonel, L. N., Bernstein, L., Young, J. L., Swanson, G., West, D. W., Key, C., Liff, J. M., Glover, C. S., & Alexander, G. A. (1996) · Cited by 500

Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.

Fan, S., Smith, M. L., Rivet, D. J., Duba, D. E., Zhan, Q., Kohn, K. W., Fornace, A. J., & O'Connor, P. M. (1995) · PubMed · Cited by 490

The national cancer data base report on pancreatic cancer

Niederhuber, J. E., Brennan, M. F., & Menck, H. R. (1995) · Cancer · doi:10.1002/1097-0142(19951101)76:9<1671::aid-cncr2820760926>3.0.co;2-r · Cited by 426

Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.

Yamanaka, Y., Frieß, H., Kobrin, M. S., et al. (1993) · PubMed · Cited by 411

High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

Seo, Y., Baba, H., Fukuda, T., Takashima, M., & Sugimachi, K. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2239::aid-cncr6>3.0.co;2-v · Cited by 400

Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases

Carraway III, K. L., Weber, J. L., Unger, M. J., Ledesma, J., Yu, N., Gassmann, M., & Lai, C. (1997) · Nature · doi:10.1038/387512a0 · Cited by 394

Prognostic significance of angiogenesis in human pancreatic cancer

Ikeda, N., Adachi, M., Taki, T., Huang, C., Hashida, H., Takabayashi, A., Sho, M., Nakajima, Y., Kanehiro, H., Hisanaga, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690248 · Cited by 316

Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage.

Yamanaka, Y., Frieß, H., Büchler, M. W., Beger, H. G., Uchida, E., Onda, M., Kobrin, M. S., & Korc, M. (1993) · PubMed · Cited by 315

Untitled work

(2001) · PubMed · Cited by 309

Isolation and Properties of a Thrombin-sensitive Protein of Human Platelets

Baenziger, N. L., Brodie, G. N., & Majerus, P. W. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45271-x · Cited by 307

High frequency of Ki‐ras codon 12 mutations in pancreatic adenocarcinomas

Grünewald, K., Lyons, J., Fröhlich, A., Feichtinger, H., Weger, R. A., Schwab, G., Janssen, J. W. G., & Bartram, C. R. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430614 · Cited by 290

Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.

Itakura, J., Ishiwata, T., Friess, H., Fujii, H., Matsumoto, Y., Büchler, M. W., & Korc, M. (1997) · PubMed · Cited by 272

Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.

Gansauge, S., Gansauge, F., Ramadani, M., Stobbe, H., Rau, B., Harada, N., & Beger, H. G. (1997) · PubMed · Cited by 261

The Physiology Of Transforming Growth Factor-α

(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60289-4 · Cited by 258

Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors

Satoh, K., Kaneko, K., Hirota, M., Masamune, A., Satoh, A., & Shimosegawa, T. (2001) · Cancer · doi:10.1002/1097-0142(20010715)92:2<271::aid-cncr1319>3.0.co;2-0 · Cited by 256

5462925 Transforming growth factor beta2,3

(1996) · Biotechnology Advances · doi:10.1016/s0734-9750(97)81916-7 · Cited by 252

The Correlation Between Cytoplasmic Overexpression of Epidermal Growth Factor Receptor and Tumor Aggressiveness: Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma

Ueda, S., Ogata, S., Tsuda, H., Kawarabayashi, N., Kimura, M., Sugiura, Y., Tamai, S., Matsubara, O., Hatsuse, K., & Mochizuki, H. (2004) · Pancreas · doi:10.1097/00006676-200407000-00061 · Cited by 245

p21Waf1/Cip1 as a therapeutic target in breast and other cancers

Weiss, R. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00308-8 · Cited by 237

Heparanase expression in primary and metastatic pancreatic cancer.

Koliopanos, A., Friess, H., Kleeff, J. H., et al. (2001) · PubMed · Cited by 237

K-ras Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance

Castells, A., Puig, P., Móra, J., Boadas, J., Boix, L., Urgell, E., Solé, M., Capellà, G., Lluís, F., Fernández-Cruz, L., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.578 · Cited by 222

Overexpression of p53 Protein in Adenocarcinoma of the Pancreas

DiGiuseppe, J. A., Hruban, R. H., Goodman, S. N., Polak, M., van Den Berg, F. M., Allison, D. C., Cameron, J. L., & Johan A. Offerhaus, G. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/101.6.684 · Cited by 218

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

Cantero, D., Friess, H., Deflorin, J., Zimmermann, A., Bründler, M.-A., Riesle, E., Korc, M., & Büchler, M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.63 · Cited by 208

Survivin as a Radioresistance Factor in Pancreatic Cancer

Asanuma, K., Moriai, R., Yajima, T., Yagihashi, A., Yamada, M., Kobayashi, D., & Watanabe, N. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00906.x · Cited by 205

Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis

Tobita, K., Kijima, H., Dowaki, S., Kashiwagi, H., Ohtani, Y., Oida, Y., Yamazaki, H., Nakamura, M., Ueyama, Y., Tanaka, M., et al. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.3.305 · Cited by 204

Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis

Moore, P. S., Orlandini, S., Zamboni, G., Capelli, P., Rigaud, G., Falconi, M., Bassi, C., Lemoine, N. R., & Scarpa, A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1567 · Cited by 197

High Expression of Vascular Endothelial Growth Factor Predicts Early Recurrence and Poor Prognosis after Curative Resection for Ductal Adenocarcinoma of the Pancreas

Niedergethmann, M., Hildenbrand, R., Wostbrock, B., Hartel, M., Sturm, J. W., Richter, A., & Post, S. (2002) · Pancreas · doi:10.1097/00006676-200208000-00002 · Cited by 191

Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.

Määttä, M., Soini, Y., Liakka, A., & Autio‐Harmainen, H. (2000) · PubMed · Cited by 178

Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma

Sarela, A. I., Verbeke, C. S., Ramsdale, J., Davies, C. L., Markham, A. F., & Guillou, P. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600133 · Cited by 178

Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Pancreatic Adenocarcinomas: Clinicopathologic and Prognostic Significance of Matrilysin Expression

Yamamoto, H., Itoh, F., Iku, S., Adachi, Y., Fukushima, H., Sasaki, S., Mukaiya, M., Hirata, K., & Imai, K. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1118 · Cited by 173

Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis

Fujimoto, K., Hosotani, R., Wada, M., Lee, J.-U., Koshiba, T., Miyamoto, Y., Tsuji, S., Nakajima, S., Doi, R., & Imamura, M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00069-0 · Cited by 168

Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis

Greten, F. R., Weber, C. K., Greten, T. F., Schneider, G., Wagner, M., Adler, G., & Schmid, R. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.37075 · Cited by 166

DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma

Biankin, A. V., Morey, A. L., Lee, C.-S., Kench, J. G., Biankin, S. A., Hook, H. C., Head, D. R., Hugh, T. B., Sutherland, R. L., & Henshall, S. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.063 · Cited by 163

Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma

Safran, H., Steinhoff, M., Mangray, S., Rathore, R., King, T. C., Chai, L., Berzein, K., Moore, T., Iannitti, D., Reiss, P., et al. (2001) · American Journal of Clinical Oncology · doi:10.1097/00000421-200110000-00016 · Cited by 162

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer.

Duffy, J. P., Eibl, G., Reber, H. A., & Hines, O. J. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-12 · Cited by 162

Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma

Ellis, L. M., Takahashi, Y., Fenoglio, C. J., Cleary, K. R., Bucana, C. D., & Evans, D. B. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10068-5 · Cited by 159

Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma

Koshiba, T., Hosotani, R., Wada, M., Miyamoto, Y., Fujimoto, K., Lee, J.-U., Doi, R., Arii, S., & Imamura, M. (1998) · Cancer · Cited by 155

Molecular Prognostic Markers in Pancreatic Cancer

Coppola, D. (2000) · Cancer Control · doi:10.1177/107327480000700504 · Cited by 153

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16INK4A, p21WAF-1, cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma

Kawesha, A., Ghaneh, P., Andrén‐Sandberg, Å., Ögraed, D., Skar, R., Dawiskiba, S., Evans, J. D., Campbell, F., Lemoine, N. R., & Neoptolemos, J. P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001120)89:6<469::aid-ijc1>3.0.co;2-l · Cited by 152

Expression of Integrin αVβ3 in Pancreatic Carcinoma: Relation to MMP-2 Activation and Lymph Node Metastasis

Hosotani, R., Kawaguchi, M., Masui, T., Koshiba, T., Ida, J., Fujimoto, K., Wada, M., Doi, R., & Imamura, M. (2002) · Pancreas · doi:10.1097/00006676-200208000-00021 · Cited by 143

Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness.

Shimoyama, S., Gansauge, F., Gansauge, S., Negri, G., Oohara, T., & Beger, H. G. (1996) · PubMed · Cited by 137

bax , but not bcl-2 , influences the prognosis of human pancreatic cancer

Friess, H., Zhao, L., Graber, H. U., Zimmermann, A., Adler, G., Korc, M., Schmid, R. M., & Büchler, M. W. (1998) · Gut · doi:10.1136/gut.43.3.414 · Cited by 134

Cloning and Expression of cDNA Encoding Human Betacellulin, a New Member of the EGF Family

Sasada, R., Ono, Y., Taniyama, Y., et al. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1173 · Cited by 131

Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma.

Kuniyasu, H., Ellis, L. M., Evans, D. B., Abbruzzese, J. L., Fenoglio, C. J., Bucana, C. D., Cleary, K. R., Tahara, E., & Fidler, I. J. (1999) · PubMed · Cited by 124

DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma

Allison, D. C., Piantadosi, S., Hruban, R. H., Dooley, W. C., Fishman, E. K., Yeo, C. J., Lillemoe, K. D., Pitt, H. A., Lin, P., & Cameron, J. L. (1998) · Journal of Surgical Oncology · Cited by 123

Moderate Activation of the Apoptosis Inhibitor bcl-xL Worsens the Prognosis in Pancreatic Cancer

Frieß, H., Zhao, L., Andrén‐Sandberg, Å., Berberat, P. O., Zimmermann, A., Adler, G., Schmid, R. M., & Büchler, M. W. (1998) · Annals of Surgery · doi:10.1097/00000658-199812000-00009 · Cited by 116

The Epidermal Growth Factor

Laurence, D. J. R., & Gusterson, B. A. (1990) · Tumor Biology · doi:10.1159/000217659 · Cited by 115

Molecular prognostic markers in pancreatic cancer

Ghaneh, P., Kawesha, A., Evans, J. D., & Neoptolemos, J. P. (2002) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340200000 · Cited by 114

Tumours of the pancreas.

Kircher, C. H., & Nielsen, S. W. (1976) · Europe PMC (PubMed Central) · Cited by 113

Survivin expression is a prognostic marker in pancreatic cancer patients

Kami, K., Doi, R., Koizumi, M., Toyoda, E., Mori, T., Ito, D., Fujimoto, K., Wada, M., Miyatake, S., & Imamura, M. (2004) · Surgery · doi:10.1016/j.surg.2004.05.023 · Cited by 102

A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients

Span, M., Moerkerk, P. T. M., Goeli, A. F. P. M. D., & Arends, J. W. (1996) · International Journal of Cancer · Cited by 101

A “catastrophic hypothesis” for pancreas cancer progression1 1The author thanks J. Alguacil, D. Longnecker, N. Malats, X. Mayol, M. Porta, and A. Sodhi for valuable comments and suggestions to a prior version of this manuscript, as well as for many stimulating discussions and J. Franquesa for the artwork.

Real, F. X. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00389-5 · Cited by 99

Increased Cyclin D1 in Human Pancreatic Cancer Is Associated with Decreased Postoperative Survival

Kornmann, M., Ishiwata, T., Itakura, J., Tangvoranuntakul, P., Beger, H. G., & Korc, M. (1998) · Oncology · doi:10.1159/000011879 · Cited by 95

Expression of E-cadherin, alpha-and beta-catenins in patients with pancreatic adenocarcinoma

Joo, Y., Rew, J., Park, C., & Kim, S.-J. (2002) · Pancreatology · doi:10.1159/000055903 · Cited by 92

Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis

Karayiannakis, A. J., Bolanaki, H., Syrigos, K. N., Asimakopoulos, B., Polychronidis, A., Anagnostoulis, S., & Simopoulos, C. E. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00047-8 · Cited by 91

Angiogenesis in pancreatic carcinoma

Fujioka, S., Yoshida, K., Yanagisawa, S., Kawakami, M., Aoki, T., & Yamazaki, Y. (2001) · Cancer · Cited by 90

Diagnosis of Pancreatic Cancer Using Serum Proteomic Profiling

Bhattacharyya, S., Siegel, E. R., Petersen, G. M., Chari, S. T., Suva, L. J., & Haun, R. S. (2004) · Neoplasia · doi:10.1593/neo.04262 · Cited by 90

Regulation of vascular development by fibroblast growth factors

Auguste, P., Javerzat, S., & Bikfalvi, A. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0750-0 · Cited by 90

p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer

Gerdes, B., Ramaswamy, A., Ziegler, A., Lang, S. A., Kersting, M., Baumann, R., Wild, A., Moll, R., Rothmund, Μ., & Bartsch, D. K. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00007 · Cited by 89

Growth factors and their receptors in pancreatic cancer

Ozawa, F., Frieß, H., Tempia‐Caliera, A. A., Kleeff, J. H., & B�chler, M. W. (2000) · Teratogenesis Carcinogenesis and Mutagenesis · Cited by 89

Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma

Dergham, S. T., Dugan, M. C., Kucway, R., Du, W., Kamarauskiene, D. S., Vaitkevicius, V. K., Crissman, J. D., & Sarkar, F. H. (1997) · International Journal of Pancreatology · doi:10.1007/bf02822384 · Cited by 86

VEGF-RII Influences the Prognosis of Pancreatic Cancer

Büchler, P., Reber, H. A., Büchler, M. W., et al. (2002) · Annals of Surgery · doi:10.1097/00000658-200212000-00006 · Cited by 85

Transforming Growth Factor‐Beta

Frenz, D. A., Galinović-Schwartz, V., Staecker, H., & Water, T. R. V. D. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb19596.x · Cited by 85

Enhanced Expression of the Type II Transforming Growth Factor-β Receptor Is Associated with Decreased Survival in Human Pancreatic Cancer

Wagner, M., Kleeff, J. H., Frieß, H., Büchler, M. W., & Korc, M. (1999) · Pancreas · doi:10.1097/00006676-199911000-00008 · Cited by 83

Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas

Sasaki, S., Yamamoto, H., Kaneto, H., Ozeki, I., Adachi, Y., Takagi, H., Matsumoto, T., Itoh, H., Nagakawa, T., Miyakawa, H., et al. (2003) · Oncology Reports · doi:10.3892/or.10.1.21 · Cited by 82

Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance

Doucas, H., Garcea, G., Neal, C. P., Manson, M. M., & Berry, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.11.005 · Cited by 79

Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.

Hu, Y., Watanabe, H., Ohtsubo, K., Yamaguchi, Y., Ha, A., Okai, T., & Sawabu, N. (1997) · PubMed · Cited by 77

Reduced membranous and ectopic cytoplasmic expression of ? -catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer

Qiao, Q., Ramadani, M., Gansauge, S., Gansauge, F., Leder, G. H., & Beger, H. G. (2001) · International Journal of Cancer · Cited by 74

Association of p53 Gene Mutations with Short Survival in Pancreatic Adenocarcinoma

Nakamori, S., Yashima, K., Murakami, Y., Ishikawa, O., Ohigashi, H., Imaoka, S., Yaegashi, S., Konishi, Y., & Sekiya, T. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03036.x · Cited by 73

Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.

Zhang, S. Y., Ruggeri, B., Agarwal, P., Sorling, A. F., Obara, T., Ura, H., Namiki, M., & Klein–Szanto, A. J. (1994) · PubMed · Cited by 73

Molecular pathology of primary and metastatic ductal pancreatic lesions

Ruggeri, B., Huang, L., Berger, D., Chang, H., Klein–Szanto, A. J., Goodrow, T. L., Wood, M., Obara, T., Heath, C. W., & Lynch, H. T. (1997) · Cancer · Cited by 72

Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.

Harvey, S. R., Hurd, T. C., Markus, G., Martinick, M., Penetrante, R. M., Tan, D., Venkataraman, P., DeSouza, N., Sait, S. N. J., Driscoll, D. L., et al. (2003) · PubMed · Cited by 71

Bcl-2 expression in pancreas development and pancreatic cancer progression

Campani, D., Esposito, I., Boggi, U., Cecchetti, D., Menicagli, M., Negri, F. D., Colizzi, L., Chiaro, M. D., Mosca, F., Fornaciari, G., et al. (2001) · The Journal of Pathology · doi:10.1002/path.925 · Cited by 70

Analysis of p53, p21WAF1, and TGF-β1 in Human Ductal Adenocarcinoma of the Pancreas: TGF-β1 Protein Expression Predicts Longer Survival

Coppola, D., Li, L., Fruehauf, J. P., Kyshtoobayeva, A. S., Karl, R. C., Nicosia, S. V., & Yeatman, T. J. (1998) · American Journal of Clinical Pathology · doi:10.1093/ajcp/110.1.16 · Cited by 69

Structure and function of heparin-binding EGF-like growth factor HB-EGF

Besner, G. E. (1998) · Frontiers in bioscience · doi:10.2741/a241 · Cited by 69

Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas

Ohta, T., Yamamoto, M., Numata, M., Iseki, S., Tsukioka, Y., Miyashita, T., Kayahara, M., Nagakawa, T., Miyazaki, I., Nishikawa, K., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.420 · Cited by 68

ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer

Graber, H. U., Friess, H., Kaufmann, B., Willi, D., Zimmermann, A., Korc, M., & B�chler, M. W. (1999) · International Journal of Cancer · Cited by 65

Angiogenesis and Cathepsin Expression Are Prognostic Factors in Pancreatic Adenocarcinoma after Curative Resection

Niedergethmann, M., Hildenbrand, R., Wolf, G., Verbeke, C. S., Richter, A., & Post, S. (2000) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:28:1:31 · Cited by 65

Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients.

Dong, M., Nio, Y., Tamura, K., Song, M., Guo, K., Guo, R.-X., & Dong, Y. (2000) · PubMed · Cited by 65

Population-based analysis of treatment of pancreatic cancer and Whipple resection: Department of Defense hospitals, 1989–1994

Wade, T. P., Halaby, I. A., Stapleton, D. R., et al. (1996) · Surgery · doi:10.1016/s0039-6060(96)80017-1 · Cited by 63

Human Heparanase-1 Gene Expression in Pancreatic Adenocarcinoma

Kim, A. W., Xu, X., Hollinger, E. F., et al. (2002) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(01)00087-7 · Cited by 63

Expression of thrombospondin-1 in human pancreatic adenocarcinomas: Role in matrix metalloproteinase-9 production

Qian, X., Rothman, V. L., Nicosia, R. F., & Tuszynski, G. P. (2001) · Pathology & Oncology Research · doi:10.1007/bf03032381 · Cited by 63

Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density

Kasper, H. U., Ebert, M. P., Malfertheiner, P., Roessner, A., Kirkpatrick, C. J., & Wolf, H. K. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000302 · Cited by 61

Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas.

Takao, S., Takebayashi, Y., Che, X., Shinchi, H., Natsugoe, S., Miyadera, K., Yamada, Y., Akiyama, S., & Aikou, T. (1998) · PubMed · Cited by 61

Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer

Gotoda, T., Matsumura, Y., Kondo, H. G., Saitoh, D., Shimada, Y., Kosuge, T., Kanai, Y., & Kakizoe, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00493.x · Cited by 58

Detailed Tissue Expression of bcl-2, bax, bak and bcl-x in the Normal Human Pancreas and in Chronic Pancreatitis, Ampullary and Pancreatic Ductal Adenocarcinomas

Evans, J. D., Cornford, P. A., Dodson, A. R., Greenhalf, W., Foster, C. S., & Neoptolemos, J. P. (2001) · Pancreatology · doi:10.1159/000055820 · Cited by 58

bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.

Sinicrope, F. A., Evans, D. B., Leach, S. D., Cleary, K. R., Fenoglio, C. J., Lee, J. J., & Abbruzzese, J. L. (1996) · PubMed · Cited by 56

The clinical significance of p21WAF1/CIP-1 and p53 expression in pancreatic adenocarcinoma

Dergham, S. T., Dugan, M. C., Joshi, U. S., Chen, Y. Q., Du, W., Smith, D. W., Arlauskas, P., Crissman, J. D., Vaitkevicius, V. K., & Sarkar, F. H. (1997) · Cancer · Cited by 56

Smad4 Transcriptional Pathways and Angiogenesis

Schwarte‐Waldhoff, I., & Schmiegel, W. (2002) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:31:1-3:47 · Cited by 54

Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma

Hua, Z. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i12.2764 · Cited by 54

Comparative analysis of the EGF-receptor family in pancreatic cancer: expression of HER-4 correlates with a favourable tumor stage.

Thybusch, A., Beckmann, S., & Juhl, H. H. (2001) · PubMed · Cited by 48

Abnormalities of Tumor Suppressor Gene p16 in Pancreatic Carcinoma : Immunohistochemical and Genetic Findings Compared with Clinicopathological Parameters

Ohtsubo, K., Hiroyuki, W., Yamaguchi, Y., & Norio, S. (2003) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 47

Prognostic Value of Immunohistochemical Expression of p53 in Patients with Pancreatic Cancer

Lundin, J. E., Nordling, S., von Boguslawsky, K., Roberts, P., & Haglund, C. H. (2009) · Oncology · doi:10.1159/000227545 · Cited by 44

p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer

Dong, M., Nio, Y., Yamasawa, K., Toga, T., Yue, L., & Harada, T. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10186 · Cited by 41

Expression of Heparin-Binding Epidermal Growth Factor-like Growth Factor in Pancreatic Adenocarcinoma

Ito, Y., Higashiyama, S., Takeda, T., Yamamoto, Y., Wakasa, K., & Matsuura∥, N. (2001) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:29:1:47 · Cited by 40

Expression of Bcl‐2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: Effects on clinical outcome and efficacy of adjuvant chemotherapy

Nio, Y., Dong, M., Iguchi, C., Yamasawa, K., Toga, T., Itakura, M., & Tamura, K. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1033 · Cited by 40

K-ras-2 Topographic Genotyping of Pancreatic Adenocarcinoma

Finkelstein, S. D. (1994) · Archives of Surgery · doi:10.1001/archsurg.1994.01420280037005 · Cited by 38

Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern

Valerio, A., Basso, D., Mazza, S., Baldo, G., Tiengo, A., Pedrazzoli, S., Seraglia, R., & Plebani, M. (2001) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.528 · Cited by 37

p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer

Ahrendt, S. A., Brown, H. M., KOMOROWSKI, R. A., Zhu, Y.-R., Wilson, S. D., Erickson, B. A., Ritch, P. S., Pitt, H. A., & Demeure, M. J. (2000) · Surgery · doi:10.1067/msy.2000.108052 · Cited by 36

Prognostic Value of Immunohistochemical Expression of Beta-1 Integrin in Pancreatic Carcinoma

Böttger, T. C., Maschek, H., Lobo, M., Gottwohl, R. G., Brenner, W., & Junginger, T. (1999) · Oncology · doi:10.1159/000011984 · Cited by 35

Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.

Mäkinen, K., Hakala, T., Lipponen, P., ALHAVA, E. M., & Eskelinen, M. J. (1998) · PubMed · Cited by 34

Aberrant p16INK4 expression related to clinical stage and prognosis in patients with pancreatic cancer.

Naka, T., Kobayashi, M., Ashida, K., Toyota, N., Kaneko, T., & Kaibara, N. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.5.1111 · Cited by 33

Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients

Song, M., Nio, Y., Dong, M., Tamura, K., Furuse, K., Tian, Y., He, S.-G., & Shen, K. (2000) · Journal of Surgical Oncology · Cited by 30

SMAD4/DPC4 and pancreatic cancer survival. Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res., 7: 4115-4121, 2001.

Liu, F. (2001) · PubMed · Cited by 29

Expression and Prognostic Roles of Integrins and Interleukin-1 Receptor Type I in Patients with Ductal Adenocarcinoma of the Pancreas

Sawai, H., Funahashi, H., Matsuo, Y., Yamamoto, M., Okada, Y., Hayakawa, T., & Manabe, T. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1024276821731 · Cited by 27

Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2

Qiao, J.-G. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i18.2759 · Cited by 24

Prognostic significance of c-erbB-2 gene expression in pancreatic cancer patients.

Novotný, J., Petruzelka, L. B., Vedralová, J., Kleibl, Z., Matouš, B., & Juda, L. (2001) · PubMed · Cited by 24

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma

Hu, Y.-X., Watanabe, H., Ohtsubo, K., Yamaguchi, Y., Ha, A., Motoo, Y., Okai, T., & Sawabu, N. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690466 · Cited by 23

p53 Overexpression in Lymph Node Metastases Predicts Clinical Outcome in Ductal Pancreatic Cancer

Campani, D., Boggi, U., Cecchetti, D., et al. (1999) · Pancreas · doi:10.1097/00006676-199907000-00004 · Cited by 18

Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas

Song, M., Nio, Y., Sato, Y., Tamura, K., & Furuse, K. (1996) · International Journal of Pancreatology · doi:10.1007/bf02825506 · Cited by 15

Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivatives

Minari, Y., Nio, Y., Hirahara, N., & Dong, M. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000252 · Cited by 7

Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization

Celli, J. P., Spring, B. Q., Rizvi, I., Evans, C. L., Samkoe, K. S., Verma, S., Pogue, B. W., & Hasan, T. (2010) · Chemical Reviews · doi:10.1021/cr900300p · Cited by 2,324

Cyclin D as a therapeutic target in cancer

Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370

MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis

Bloomston, M., Frankel, W. L., Petrocca, F., Volinia, S., Alder, H., Hagan, J. P., Liu, C.-G., Bhatt, D., Taccioli, C., & Croce, C. M. (2007) · JAMA · doi:10.1001/jama.297.17.1901 · Cited by 1,141

Molecular subtypes of pancreatic cancer

Collisson, E. A., Bailey, P., Chang, D. K., & Biankin, A. V. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0109-y · Cited by 892

Cyclin D1, cancer progression, and opportunities in cancer treatment

Qie, S., & Diehl, J. A. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1475-3 · Cited by 657